L. Bontempi
Please Note
2 records found
1
Introduction: Only 60% of patients with acute ischemic stroke (AIS) achieve successful reperfusion after the first endovascular thrombectomy (EVT) attempt. In vitro studies have shown that thrombus stiffness influences thrombus-device interaction and retrieval efficacy. This prospective observational study investigates how thrombus stiffness relates to clinical factors, thrombus imaging characteristics and histological composition. It further explores the association between thrombus stiffness and EVT success, as measured by the modified first-pass reperfusion (mFPR). Patients and methods: A total of 281 thrombus samples were collected from 51 AIS patients undergoing EVT. Thrombus stiffness was quantified using compressive mechanical testing, composition from histological staining and radiological characteristics from pre-interventional non-contrast computed tomography (CT) and CT angiography. Statistical analysis was performed using linear and logistic mixed-effects regression models. Results: Thrombi retrieved from the proximal M2 segment of the middle cerebral artery showed significant lower stiffness (0.236 kPa, 95% CI, 0.136–0.409) compared to those from the M1 segment (0.760 kPa, 95% CI, 0.492–1.174) and from the ICA (1.106 kPa, 95% CI, 0.558–2.192). Occlusion location was the strongest clinical marker of thrombus stiffness. Adjusted mFPR probability was 40.4% (95% CI, 24.5–67.0) for thrombi retrieved from the ICA, 89.7% (95% CI, 79.5–97.0) for M1 occlusions, and 53.0% (95% CI, 30.8–84.7) for M2 occlusions. Conclusion: Thrombi in distal vessels of the anterior cerebral circulation are significantly softer than those in proximal intracranial arteries. First-pass EVT success is lower for the stiffest thrombi from the ICA and for the softest thrombi from M2, providing a foundation for future biomechanically informed thrombus removal strategies to optimise AIS treatment.
The coagulation cascade, triggered by tissue factor (TF) exposure after endothelial injury, drives fibrin formation and may result in thrombotic events such as stroke. The mechanisms driving differences in thrombus extent among patients remain poorly understood, but interactions between patient-specific coagulation and local blood flow are thought to be critical. This study presents a unified workflow with an assay-calibrated, experimentally validated in silico model that links coagulation assays to flow-resolved simulations in patient-specific geometries. Plasma from ischemic stroke patients was analyzed with a thrombin generation (TG) assay, and a 0D computational model was fitted to TG curves to infer patient-specific coagulation parameters. These parameters were validated against thrombodynamics (TD) outcomes using 1D computational reaction–diffusion simulations. The framework was extended to 2D computational flow domains to assess the influence of shear rate, TF patch size and location, and geometric features such as stenosis. Finally, 3D carotid simulations combined patient-specific vascular geometries with plasma parameters. The 0D model reproduced TG data, while 1D simulations matched TD outcomes for clot size, fibrin growth, and thrombin wave speed. In 2D, fibrin formation was reduced at higher shear or smaller TF patches, and 3D simulations demonstrated the combined effect of flow, geometry, and plasma composition on fibrin formation. This approach provides a bridge from bench assays to hemodynamic contexts and offers a potential path toward individualized thrombotic risk assessment.